Japan Puts "Epidemic" Label On H1N1 Flu Outbreak As Three Die
This article was originally published in PharmAsia News
Japan's healthy ministry has made it official -- the nation is undergoing an epidemic of the H1N1 flu. Health, Labor and Welfare Minister Yoichi Masuzoe said the nation has undergone a rapid increase in infections from the virus, prompting the declaration. The infections include three deaths from the disease in just a few days. (Click here for more - a subscription may be required
You may also be interested in...
Executives On The Move: BMS Taps Barclays Exec For Strategy Spot, Epizyme Selects Science Chief And A Board Election At ADC Therapeutics
Bristol-Myers Squibb taps Barclays chair of global life sciences as it EVP, strategy and business development, and cancer therapeutics firm Epizyme Inc. selects a chief scientific officer. At ADC Therapeutics, an oncology drug development company, a new chairman is elected.
Non-CE-marked products on the EU market, virtual notified body audits, free standards and the Commission bid to pause the MDR. March has seen unprecedented developments as COVID-19 has railroaded through the sector decimating regulatory rules and plans.
Jubilant Life Sciences anticipates continued strong demand despite temporary logistics blips in India and expects to resume operations at its Nanjangud plant, currently shut down due to a few COVID-19 cases among employees, by mid-April. It is also evaluating the feasibility of manufacturing some of the APIs recently incentivized by the Indian government.